Key result
ZNF283 inhibits PRRSV replication and RNA synthesis by interacting with viral proteins Nsp9 and Nsp10.
Why the study?
Existing vaccination strategies and antiviral drugs offer limited protection against PRRSV, a pathogen with substantial economic implications for the swine industry.
ZNF283 is an antiviral factor that inhibits PRRSV infection by interacting with viral proteins Nsp9 and Nsp10.
ZNF283 may serve as PRRSV antiviral target; leaves open translation to in vivo swine models.
Porcine reproductive and respiratory syndrome virus (PRRSV) is a viral pathogen with substantial economic implications for the global swine industry. The existing vaccination strategies and antiviral drugs offer limited protection. Replication of the viral RNA genome encompasses a complex series of steps, wherein a replication complex is assembled from various components derived from both viral and cellular sources, as well as from the viral genomic RNA template. In this study, we found that ZNF283, a Krüppel-associated box (KRAB) containing zinc finger protein, was upregulated in PRRSV-infected Marc-145 cells and porcine alveolar macrophages and that ZNF283 inhibited PRRSV replication and RNA synthesis. We also found that ZNF283 interacts with the viral proteins Nsp9, an RNA-dependent RNA polymerase, and Nsp10, a helicase. The main regions involved in the interaction between ZNF283 and Nsp9 were determined to be the KRAB domain of ZNF283 and amino acids 178-449 of Nsp9. The KRAB domain of ZNF283 plays a role in facilitating Nsp10 binding. In addition, ZNF283 may have an affinity for the 3' untranslated region of PRRSV. These findings suggest that ZNF283 is an antiviral factor that inhibits PRRSV infection and extend our understanding of the interactions between KRAB-containing zinc finger proteins and viruses.
No takes yet. Share an insight, caveat, or question.
Yi et al. (2024) studied Porcine reproductive and respiratory syndrome virus (PRRSV) infection (in vitro). ZNF283 overexpression or knockdown vs. Empty vector or scrambled shRNA was evaluated on Viral replication and RNA synthesis (viral titers and protein expression). ZNF283 acts as an antiviral factor that inhibits PRRSV replication and RNA synthesis by interacting with the viral proteins Nsp9 and Nsp10.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: